Conor E. Steuer, MD

One star
One star
One star
One star
One half star

Rating: 4.8 out of 5 (157 ratings)

Role

Medical Oncology
Specialty

Head and Neck Cancer Lung Cancer Thyroid Cancer Esophageal Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2015

Call 404-778-1900

Background

Conor E. Steuer, MD, is a board certified medical oncologist specializing in the care of aerodigestive cancers, mesothelioma and thymic malignancies. He joined the clinical staff at Winship Cancer Institute as a practicing physician in 2015.

Dr. Steuer is an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. He currently serves as chair of the Lung and Aerodigestive Malignancies Working Group.

Dr. Steuer received his medical degree from NYU School of Medicine. He completed his postdoctoral training as a Fellow in the Department of Hematology and Medical Oncology at Emory University School of Medicine where he was Chief Fellow in his final year.

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Hematology & Oncology, 2015
Emory University School of Medicine
Residency, Internal Medicine, 2012
Emory University School of Medicine
Medical Education, MD, 2009
New York University

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2015
Hematology
American Board of Internal Medicine, 2015
Internal Medicine
American Board of Internal Medicine, 2012

Research

Dr. Steuer has been active in research including clinical trial development, database analyses, and investigation of molecular biomarkers. He is interested in investigating the molecular biology and genomics of thoracic and head and neck tumors in order to be able to further the care of these patient populations. Additionally, he has taken an interest in utilizing national databases to perform clinical outcomes research, as well as further investigate rare forms of thoracic cancers.

View Current Clinical Trials


Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer Phase II Conditions Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Location Emory University Hospital Midtown, Winship Cancer Institute
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer Phase II Conditions Advanced Lung Adenocarcinoma, Refractory Lung Adenocarcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers Phase II Conditions Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma Location Emory University Hospital Midtown, Winship Cancer Institute
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Phase II Conditions Salivary Gland Cancer, HER2 Gene Mutation Location Emory University Hospital Midtown
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer Phase I Conditions Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8 Location Emory University Hospital Midtown, Winship Cancer Institute
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) Phase I Conditions Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer, Melanoma, Gastric Cancer, Renal Cell Carcinoma, Urothelial Carcinoma Location Emory University Hospital Midtown, Winship Cancer Institute

Publications

Dr. Steuer's work has been published in many leading journals, such as Cancer, Journal of Thoracic Oncology, and Lung Cancer, as well as presented at multiple international conferences.

Title/Journal

Authors

Publication Date

02/16/2026

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.8	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.8	One star One star One star One star One half star	Provider discussed treatment options
4.8	One star One star One star One star One half star	Provider included you in decisions
4.8	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	01/06/2026	The best
One star One star One star One star One star	12/09/2025	Dr. Steuer is wonderful. So is his PA Courtney who we have seen multiple times but not for this visit. Dr. Steuer is kind, intelligent, up to date on current evidence, trials and standard of care. He individualized our treatment plan taking into account preferences and health status. He has been very supportive throughout this arduous journey and we are so grateful for him and all of our Emory team.
One star One star One star One star One star	12/07/2025	Dr. Steuer was very positive, reassuring and hopeful. He listened to all of our concerns, answered our questions and provided helpful suggestions.
One star One star One star One star One star	10/07/2025	Exceptional visit with both listening and also explanations
One star One star One star One star One star	07/19/2025	Again it was just very comfortable meeting. I felt like he explained everything well and used language that made me understand. In Oncology that isn't always easy to do.
One star One star One star One star One star	07/15/2025	Great communication.
One star One star One star One star One star	06/25/2025	I tell everyone how great Emory is!!! My doctors, surgeons, and their associated staffs are tops!!!
One star One star One star One star One star	05/24/2025	I hoe none of my family or friends needs this type of doctor but if they did I'd recommend him
One star One star One star One star One star	05/23/2025	If I could rate these areas a 10, I would.
One star One star One star One star One star	05/14/2025	Truly excellent
One star One star One star One star One star	05/02/2025	Dr Steuer is always ahead on the latest cancer treatments. Fortunate to have him on my team!
One star One star One star One star One star	03/20/2025	Very professional, respectful of my wishes. Well-educated and concerned for my well-being. I visited two other cancer centers and ultimately chose Emory due to the confidence in and comfort felt with Dr. Steuer. He listened and prioritized my needs over his own agenda.
One star One star One star One star One star	01/19/2025	Dr. Steuer is the best!
One star One star One star One star One star	01/17/2025	First appointment with this doctor. Felt very at ease and he showed interest ion my questions, etc. I was so very pleased.
One star One star One star One star One star	01/11/2025	Dr Steuer is very professional and knowledgeable. He is great Dr to take care of patients
One star One star One star One star One star	12/06/2024	Very Good
One star One star One star One star One star	11/06/2024	Listened carefullly and provided guidance on what the next step should be.
One star One star One star One star One star	10/27/2024	Feel like Dr Steuer is genuinely interested and open to all possible protocols to beat cancer. He is very accessible and shows true care for my quality of life.
One star One star One star One star One star	10/26/2024	Dr. Steuer Is absolutely the best and his staff are outstanding!
One star One star One star One star One star	10/16/2024	Everybody that talked to me.Seemed to be on the same page and knew what the situation was.I'm very pleased
One star One star One star One star One star	09/18/2024	Excellent
One star One star One star One star One star	07/23/2024	Dr Steuer provided the options I have, fully explaining them. Answered all questions asked and addressed our concerns.
One star One star One star One star One star	07/22/2024	Always tell people to use my Dr
One star One star One star One star One star	03/09/2024	Dr. Stuer has been amazing and I truly appreciate him.